Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?

Current diabetes reviews - 1 Jan 2018

Scott Susanne I, Andersen Michelle Fog, Aagaard Lise, Buchwald Christian Von, Rasmussen Eva R

Abstract excerpt

INTRODUCTION: Angioedema is a potentially fatal adverse drug reaction of some medications, as swellings of the upper airways can cause death by asphyxiation. Angiotensin converting enzymeinhibitors are widely known to cause angioedema but less is known about the association between dipeptidyl peptidase-4 inhibitors (gliptins) and angioedema. Dipeptidyl peptidase-4 inhibitors are antidiabetic drugs used to improve...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioedema
Share to Angiotensin-Converting Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bradykinin

Share to Capillary Permeability

Share to Dipeptidyl Peptidase 4

Share to Drug Interactions

Share to Substance P

Share to Vasodilation

Source

Identifiers

PMID: 28201967
DOI: 10.2174/1573399813666170214113856

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?PMID 28201967Read ↗

Angiotensin-converting enzyme inhibitor-associated angioedema.Semantic proximity Read ↗

Drugs of the Kallikrein-Kinin System: An OverviewSemantic proximity Read ↗

Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches.Semantic proximity Read ↗

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.Semantic proximity Read ↗

Angioedema without urticaria: Diagnosis and management.Semantic proximity Read ↗

Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.Semantic proximity Read ↗

[Physiopathology of the acute adverse effects of angiotensin-converting-enzyme inhibitors].Semantic proximity Read ↗

ACE inhibitor-mediated angioedemaSemantic proximity Read ↗

Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.Semantic proximity Read ↗

Angioedema beyond histamine: an educational case series.Semantic proximity Read ↗

Common variants near the bradykinin receptor B<sub>2</sub>gene are associated with angioedema induced by angiotensin-converting-enzyme inhibitor treatment - a genome wide association studySemantic proximity Read ↗

Prediction and prevention of ACE-inhibitor-induced angioedema—an unmet clinical need in management of hypertensionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.